In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Fosun Pharma agrees to acquire generics company Gland Pharma; later revises deal terms

Executive Summary

Shanghai Fosun Pharmaceutical Group Co. Ltd. agreed to acquire an 86% stake in generic injectables company Gland Pharma Ltd. for $1.26bn in cash. The shares are being purchased from KKR Floorline Investments (first invested in 2014) and other company shareholders. P.V.N. Raju, Gland's founder, and his son Dr. Ravi Penmetsa will retain a stake in the company.
Deal Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Generic Drugs
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Includes Earnout
    • Partial Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register